http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2017001373-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bceb71676971f1383ae2a7e5ccaa7da
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2017-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4e6c843f4bdc13696b0df05dab66e2f
publicationDate 2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2017001373-A1
titleOfInvention Anti-cancer compositions
abstract <p> THE PRESENT INVENTION REFERS TO ARN-509 PHARMACEUTICAL FORMULATIONS THAT MAY BE ADMINISTERED TO A MAMMAL, PARTICULARLY TO A HUMAN BEING, WHO LIKES OF AN ILLNESS OR AFFECTION RELATED TO THE ANDROGENIC RECEPTOR, PARTICULAR, PARTICULAR MORE PROSTATE CANCER, INCLUDING, BY MERELY ENUNCIATIVE TITLE, PROSTATION CANCER RESISTANT TO CASTRATION, PROSTATE CANCER WITH CASTRATION RESISTANT METASTATION, PROSTATE CANCER WITH METAL RESISTANCE TO CASTRATIA WITHOUT QUESTION AT QUESTION HORMONES WITH BIOCHEMICAL RECYCLES OR NON-METASTASSIC PROSTATE CANCER RESISTANT TO CASTRATION AND HIGH RISK. IN AN ASPECT, THESE FORMULATIONS INCLUDE A SOLID DISPERSION OF RNA-509, A COPOLYMER OF POLY (MET) ACRYLATE AND HPI'4CAS. IN AN APPEARANCE, THE SOLID DISPERSION OF RNA-509, A COPOLYMER OF POLY (MET) ACRYLATE AND HPMCAS CAN BE OBTAINED, PARTICULARLY OBTAINED, THROUGH THE FUSION EXTRUSION OF A MIXTURE THAT INCLUDES RNA-509, A POLYMER METHOD ) ACRYLATE AND HPMCAS AND, OPTIONALLY, GRINDING AFTER SUCH MIXTURE EXTRUDED BY FUSION. IN AN APPEARANCE, THE SOLID DISPERSION OF RNA-509, A COPOLYMER OF POLY (MET) ACRYLATE AND HPMCAS CAN BE OBTAINED, PARTICULARLY OBTAINED, BY SPRAY DEHYDRATION OF A MIXTURE THAT INCLUDES METR-50M COPY ) ACRYLATE AND HPMCAS IN A SUITABLE SOLVENT. </p>
priorityDate 2014-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454668499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474459

Total number of triples: 25.